DIA 2013 49th Annual Meeting
Click here to go to the previous page
Tracking Misuse and Abuse of Marketed Products: Is Pharma Doing All that It Can?
Track
:
Track 14: Clinical Safety and Pharmacovigilance
Program Code:
413
Date:
Thursday, June 27, 2013
Time:
9:00 AM to 10:30 AM
EST
Location:
153AB
CHAIR
:
Mitch Miller, PharmD (SCHNON), Director, Publications and Medical Writing, Drug Safety Alliance, Inc., United States
SPEAKER
(S):
Barbara Leishman, MA (SCHNON), External Business Alliance Leader, F. Hoffmann-La Roche Ltd., Switzerland Rick L. Seibert, MBA,MS,PMP (SPKNON), Vice President, Project Management and New Business Development and Engineering, Sharp Corporation, United States
Description
This session will discuss if pharmaceutical companies are doing all that they can to ensure accurate communication of the risks involved in misuse of certain medications, and if they are appropriately tracking all adverse event reports received as a result of product misuse. This session will focus on the best practices involved in monitoring, tracking and reporting off-label use and misuse and abuse of pharmaceutical products.
This session is a part of:
This session is a part of: